[HTML][HTML] Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma
PS Ramalingam, A Priyadharshini, IA Emerson… - Frontiers in …, 2023 - frontiersin.org
Background Mutant KRAS-induced tumorigenesis is prevalent in lung, colon, and pancreatic
ductal adenocarcinomas. For the past 3 decades, KRAS mutants seem undruggable due to …
ductal adenocarcinomas. For the past 3 decades, KRAS mutants seem undruggable due to …
Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma
P Ramalingam, A Priyadharshini, I Emerson… - Frontiers in …, 2023 - europepmc.org
Background Mutant KRAS-induced tumorigenesis is prevalent in lung, colon, and pancreatic
ductal adenocarcinomas. For the past 3 decades, KRAS mutants seem undruggable due to …
ductal adenocarcinomas. For the past 3 decades, KRAS mutants seem undruggable due to …
Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma
PS Ramalingam, A Priyadharshini… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Mutant KRAS-induced tumorigenesis is prevalent in lung, colon, and pancreatic
ductal adenocarcinomas. For the past 3 decades, KRAS mutants seem undruggable due to …
ductal adenocarcinomas. For the past 3 decades, KRAS mutants seem undruggable due to …
[HTML][HTML] Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma
PS Ramalingam, A Priyadharshini, IA Emerson… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background Mutant KRAS-induced tumorigenesis is prevalent in lung, colon, and pancreatic
ductal adenocarcinomas. For the past 3 decades, KRAS mutants seem undruggable due to …
ductal adenocarcinomas. For the past 3 decades, KRAS mutants seem undruggable due to …
Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma
PS Ramalingam, A Priyadharshini… - … medicines, volume II, 2023 - books.google.com
Background: Mutant KRAS-induced tumorigenesis is prevalent in lung, colon, and
pancreatic ductal adenocarcinomas. For the past decades, KRAS mutants seem …
pancreatic ductal adenocarcinomas. For the past decades, KRAS mutants seem …
Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma.
PS Ramalingam, A Priyadharshini, IA Emerson… - Frontiers in …, 2023 - europepmc.org
Background Mutant KRAS-induced tumorigenesis is prevalent in lung, colon, and pancreatic
ductal adenocarcinomas. For the past 3 decades, KRAS mutants seem undruggable due to …
ductal adenocarcinomas. For the past 3 decades, KRAS mutants seem undruggable due to …